Spatial Changes in the Atrial Fibrillation Wave-Dynamics After Using Antiarrhythmic Drugs: A Computational Modeling Study
- PMID: 34630153
- PMCID: PMC8497701
- DOI: 10.3389/fphys.2021.733543
Spatial Changes in the Atrial Fibrillation Wave-Dynamics After Using Antiarrhythmic Drugs: A Computational Modeling Study
Erratum in
-
Corrigendum: Spatial changes in the atrial fibrillation wave-dynamics after using antiarrhythmic drugs: A computational modeling study.Front Physiol. 2022 Dec 15;13:992000. doi: 10.3389/fphys.2022.992000. eCollection 2022. Front Physiol. 2022. PMID: 36589458 Free PMC article.
Abstract
Background: We previously reported that a computational modeling-guided antiarrhythmic drug (AAD) test was feasible for evaluating multiple AADs in patients with atrial fibrillation (AF). We explored the anti-AF mechanisms of AADs and spatial change in the AF wave-dynamics by a realistic computational model. Methods: We used realistic computational modeling of 25 AF patients (68% male, 59.8 ± 9.8 years old, 32.0% paroxysmal AF) reflecting the anatomy, histology, and electrophysiology of the left atrium (LA) to characterize the effects of five AADs (amiodarone, sotalol, dronedarone, flecainide, and propafenone). We evaluated the spatial change in the AF wave-dynamics by measuring the mean dominant frequency (DF) and its coefficient of variation [dominant frequency-coefficient of variation (DF-COV)] in 10 segments of the LA. The mean DF and DF-COV were compared according to the pulmonary vein (PV) vs. extra-PV, maximal slope of the restitution curves (Smax), and defragmentation of AF. Results: The mean DF decreased after the administration of AADs in the dose dependent manner (p < 0.001). Under AADs, the DF was significantly lower (p < 0.001) and COV-DF higher (p = 0.003) in the PV than extra-PV region. The mean DF was significantly lower at a high Smax (≥1.4) than a lower Smax condition under AADs. During the episodes of AF defragmentation, the mean DF was lower (p < 0.001), but the COV-DF was higher (p < 0.001) than that in those without defragmentation. Conclusions: The DF reduction with AADs is predominant in the PVs and during a high Smax condition and causes AF termination or defragmentation during a lower DF and spatially unstable (higher DF-COV) condition.
Keywords: antiarrhythmic drug; atrial fibrillation; computational modeling; dominant frequency; spatial changes.
Copyright © 2021 Hwang, Park, Kwon, Lim, Lee, Jin, Yu, Kim, Joung and Pak.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures





Similar articles
-
Ablation and antiarrhythmic drug effects on PITX2 +/- deficient atrial fibrillation: A computational modeling study.Front Cardiovasc Med. 2022 Jul 19;9:942998. doi: 10.3389/fcvm.2022.942998. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35928934 Free PMC article.
-
Computational Modeling for Antiarrhythmic Drugs for Atrial Fibrillation According to Genotype.Front Physiol. 2021 May 13;12:650449. doi: 10.3389/fphys.2021.650449. eCollection 2021. Front Physiol. 2021. PMID: 34054570 Free PMC article.
-
Anti-atrial Fibrillation Effects of Pulmonary Vein Isolation With or Without Ablation Gaps: A Computational Modeling Study.Front Physiol. 2022 Mar 17;13:846620. doi: 10.3389/fphys.2022.846620. eCollection 2022. Front Physiol. 2022. PMID: 35370797 Free PMC article.
-
Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.Am J Cardiol. 2003 Mar 20;91(6A):15D-26D. doi: 10.1016/s0002-9149(02)03375-1. Am J Cardiol. 2003. PMID: 12670638 Review.
-
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.Cochrane Database Syst Rev. 2019 Sep 4;9(9):CD005049. doi: 10.1002/14651858.CD005049.pub5. Cochrane Database Syst Rev. 2019. PMID: 31483500 Free PMC article.
Cited by
-
Clinical Usefulness of Virtual Ablation Guided Catheter Ablation of Atrial Fibrillation Targeting Restitution Parameter-Guided Catheter Ablation: CUVIA-REGAB Prospective Randomized Study.Korean Circ J. 2022 Sep;52(9):699-711. doi: 10.4070/kcj.2022.0113. Epub 2022 Jul 11. Korean Circ J. 2022. PMID: 35927040 Free PMC article.
-
Challenges and Opportunities for Atrial Fibrillation Management.Cardiol Discov. 2025 Jun;5(2):149-161. doi: 10.1097/CD9.0000000000000155. Epub 2025 Apr 10. Cardiol Discov. 2025. PMID: 40535757 Free PMC article. Review.
-
Clinical usefulness of digital twin guided virtual amiodarone test in patients with atrial fibrillation ablation.NPJ Digit Med. 2024 Oct 23;7(1):297. doi: 10.1038/s41746-024-01298-z. NPJ Digit Med. 2024. PMID: 39443659 Free PMC article.
-
Computational modeling of cardiac electrophysiology and arrhythmogenesis: toward clinical translation.Physiol Rev. 2024 Jul 1;104(3):1265-1333. doi: 10.1152/physrev.00017.2023. Epub 2023 Dec 28. Physiol Rev. 2024. PMID: 38153307 Free PMC article. Review.
-
Network Pharmacology and Pharmacological Mechanism of CV-3 in Atrial Fibrillation.Evid Based Complement Alternat Med. 2022 Jun 14;2022:5496299. doi: 10.1155/2022/5496299. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35747377 Free PMC article.
References
-
- Bai J., Zhu Y., Lo A., Gao M., Lu Y., Zhao J., et al. (2021). In silico assessment of class I Antiarrhythmic drug effects on Pitx2-induced atrial fibrillation: insights from populations of electrophysiological models of human atrial cells and tissues. Int. J. Mol. Sci. 22:1265. 10.3390/ijms22031265 - DOI - PMC - PubMed
-
- Chen S. A., Hsieh M. H., Tai C. T., Tsai C. F., Prakash V. S., Yu W. C., et al. (1999). Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation 100 1879–1886. 10.1161/01.cir.100.18.1879 - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous